Role of interleukin-1 beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice

Interleukin-1 (IL-1) mediates symptoms of sickness during the host response to infection. IL-1 exerts its effects via several subtypes of receptors, T o assess the role of IL-1 receptor type 1 (IL-1RI) in the sickness-inducing effects of IL-1, IL-1 beta and the cytokine inducer lipopolysaccharide wer e administered to IL-1RI-deficient mice (IL-1RI-/-). Sickness was assessed by depression of social exploration, anorexia, immobility and body weight l oss. IL-1RI-/- mice were resistant to the sickness-inducing effects of IL-1 beta administered intraperitoneally (2 mug/mouse) and intracerebroventricu larly (2 ng/mouse), but still fully responsive to lipopolysaccharide admini stered intraperitoneally (2.5 mug/mouse) and intracerebroventricularly (3 n g/mouse). The sensitivity of IL-1RI-/- mice to lipopolysaccharide was not d ue to a higher brain expression of proinflammatory cytokines other than IL- 1, since lipopolysaccharide-induced expression of brain IL-1 beta, tumour n ecrosis factor-alpha (TNF-alpha) and IL-6 transcripts were identical in IL- 1RI-/- and control mice when measured by semiquantitative reverse-transcrip tase polymerase chain reaction 1 h after treatment. Blockade of TNF-alpha a ction in the brain by intracerebroventricular administration of a fragment of the soluble TNF receptor, TNF binding protein (3.6 mug/mouse), attenuate d the depressive effects of intraperitoneal injection of lipopolysaccharide (1 mug/mouse) on behaviour in IL-1RI-/- but not in control mice. Since IL- 1RI-/- mice were not more sensitive to intracerebroventricularly TNF-alpha (50 ng) than control mice, these results indicate that IL-1RI mediates the sickness effect of IL-1 and that TNF-alpha simply replaces IL-1 when this l ast cytokine is deficient.